Skip to main content
Figure 3 | BMC Medicine

Figure 3

From: Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials

Figure 3

Effects of PDE5i over placebo on cardiac performance and blood pressure. A) Main analysis on the cardiac index (L/min/m2); B) Main analysis on EF (%); C) main analysis on SBP (mmHg) and D) main analysis on DPB (mmHg). Diamond indicates the overall summary estimate for the analysis (width of the diamond represents the 95% CI); boxes indicate the weight of individual studies in the pooled analysis. CI: confidence interval; PDE5i: phosphodiesterase type 5 inhibitors.

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us